AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS
- PMID: 38627359
- PMCID: PMC11021507
- DOI: 10.1038/s41420-024-01949-w
AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS
Abstract
Mitochondrial dysfunction represents one of the most common molecular hallmarks of both sporadic and familial forms of amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder caused by the selective degeneration and death of motor neurons. The accumulation of misfolded proteins on and within mitochondria, as observed for SOD1 G93A mutant, correlates with a drastic reduction of mitochondrial respiration and the inhibition of metabolites exchanges, including ADP/ATP and NAD+/NADH, across the Voltage-Dependent Anion-selective Channel 1 (VDAC1), the most abundant channel protein of the outer mitochondrial membrane. Here, we show that the AAV-mediated upregulation of VDAC1 in the spinal cord of transgenic mice expressing SOD1 G93A completely rescues the mitochondrial respiratory profile. This correlates with the increased activity and levels of key regulators of mitochondrial functions and maintenance, namely the respiratory chain Complex I and the sirtuins (Sirt), especially Sirt3. Furthermore, the selective increase of these mitochondrial proteins is associated with an increase in Tom20 levels, the receptor subunit of the TOM complex. Overall, our results indicate that the overexpression of VDAC1 has beneficial effects on ALS-affected tissue by stabilizing the Complex I-Sirt3 axis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig5_HTML.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11021507/bin/41420_2024_1949_Fig6_HTML.gif)
Similar articles
-
Small Hexokinase 1 Peptide against Toxic SOD1 G93A Mitochondrial Accumulation in ALS Rescues the ATP-Related Respiration.Biomedicines. 2021 Aug 3;9(8):948. doi: 10.3390/biomedicines9080948. Biomedicines. 2021. PMID: 34440152 Free PMC article.
-
Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS.Int J Mol Sci. 2022 Sep 1;23(17):9946. doi: 10.3390/ijms23179946. Int J Mol Sci. 2022. PMID: 36077343 Free PMC article.
-
A VDAC1-Derived N-Terminal Peptide Inhibits Mutant SOD1-VDAC1 Interactions and Toxicity in the SOD1 Model of ALS.Front Cell Neurosci. 2019 Aug 14;13:346. doi: 10.3389/fncel.2019.00346. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31474832 Free PMC article.
-
Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration.Rev Neurosci. 2007;18(2):115-36. doi: 10.1515/revneuro.2007.18.2.115. Rev Neurosci. 2007. PMID: 17593875 Review.
-
SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis.Front Cell Neurosci. 2015 Aug 25;9:336. doi: 10.3389/fncel.2015.00336. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26379505 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous